Two studies linked a type of lesions with chronic inflammation, paramagnetic rim lesions, with worse MS disability ...
Participants had a median age of 54 at enrollment and two-thirds (67.4%) were female. Most participants (90%) had ...
Established drug, new application "Fampridine doesn't improve ... The drug is currently used to improve walking ability in multiple sclerosis (MS). Particularly in capsule form, which releases ...
In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long ...
UB researchers have published the first longitudinal studies of paramagnetic rim lesions, an indicator of brain inflammation in MS.
Current treatments are focused on functional control of these activated autoimmune T cells, but these treatments are non-specific T cell inhibitors and have serious, sometimes fatal side effects.
Hosted on MSN20d
Peterborough mum joins ground-breaking University of Cambridge medical trial into new treatments for MSEarlier this year she joined the CCMR2 trial at the University of Cambridge, funded by the MS Society. Researchers are testing whether a combination of two treatments could help repair myelin ...
A research team at Case Western Reserve University is pioneering a novel approach to MS treatment by targeting toxic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback